Recombinant FVIIIFc Versus BAY 94-9027 For Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison
mediaposted on 23.12.2020, 16:09 by Zalmai Hakimi, Elena Santagostino, Maarten J. Postma, Jameel Nazir
Article full text
The article associated with this page has been accepted for online publication and is in the final stages of production. The pre-typeset version is available above.
© The authors, CC-BY-NC 2020.